AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BioTech Medics, Inc.

$0.00 -$0.01 (-97.47%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$0.00
Day Range
$0.00$0.01
Year Range
$0.00$0.01
Market Cap
41.07K
AVG Volume
1.19K
Trailing/Forward PE
-13.86/-
PEG ratio
0.05
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD) · TTM
-150K-100K-50K050K22 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q1
BMCS Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
25 Q16.25K
24 Q4-2.92K
24 Q3-49.2K
24 Q2-19.18K
24 Q1-15.74K
23 Q4-5.62K
23 Q3-13.97K
23 Q2-29.76K
23 Q1-64.93K
22 Q4-114.82K
Operating Income (USD) · TTM
-150K-100K-50K050K22 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q1
BMCS Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
25 Q16.25K
24 Q4-2.92K
24 Q3-77.41K
24 Q2-47.82K
24 Q1-38.44K
23 Q4-28.33K
23 Q3-13.97K
23 Q2-29.77K
23 Q1-64.94K
22 Q4-114.82K
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
BioTech Medics, Inc.
BMCS
Stockpicker

Video analysis: BMCS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BMCS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.